The latest closing stock price for Mineralys Therapeutics as of February 21, 2025 is 9.56.
An investor who bought $1,000 worth of Mineralys Therapeutics stock at the IPO in 2023 would have $-482 today, roughly 0 times their original investment - a -28.00% compound annual growth rate over 2 years.
The all-time high Mineralys Therapeutics stock closing price was 19.14 on March 03, 2023.
The Mineralys Therapeutics 52-week high stock price is 16.91, which is 76.9% above the current share price.
The Mineralys Therapeutics 52-week low stock price is 8.58, which is 10.3% below the current share price.
The average Mineralys Therapeutics stock price for the last 52 weeks is 12.38.
An investor who bought $1,000 worth of Mineralys Therapeutics stock at the IPO in 2023 would have $-482 today, roughly 0 times their original investment - a -28.00% compound annual growth rate over 2 years.
The all-time high Mineralys Therapeutics stock closing price was 19.14 on March 03, 2023.
The Mineralys Therapeutics 52-week high stock price is 16.91, which is 76.9% above the current share price.
The Mineralys Therapeutics 52-week low stock price is 8.58, which is 10.3% below the current share price.
The average Mineralys Therapeutics stock price for the last 52 weeks is 12.38.